Shares in Alcon fell as much as 11.6% on Wednesday after the Swiss-American eye care group cut its 2025 sales outlook late on ...

Swiss-American eye care firm Alcon Inc (NYSE:ALC) stock slumped on Wednesday after the company cut its 2025 outlook late on ...

Alcon (NYSE:ALC) is down ~9% in Wednesday trading after releasing Q2 financial results after Tuesday's closing bell that ...

Alcon shares fell after the Swiss eye-care giant trimmed its full-year guidance due to President Trump’s trade tariffs.

Alcon remains a leader in eye care, benefiting from strong market positioning and long-term industry tailwinds. Read the ...

Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

The company forecasts a full-year gross tariff impact of around $100 million, up from $80 million expected previously ...

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

Gain insights from Alcon Inc.'s Q2 2025 earnings call, including new product launches, strategic acquisitions, market trends, and updated financial guidance.

For almost four decades, Tom McDonald was a part of the team at Fort Worth-born Alcon, which continues to make innovative moves in the world of eyecare products. He recaps the company’s first five ...

Global eye care leader Alcon has announced it will acquire Lake Forest-based Staar Surgical, a manufacturer of implantable ...

Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced a strong presence at the ...